IBM Corp.

Company Snapshot

Founded: 1911
Entity Type: Public
Employees: 200,000
Region: U.S.
Revenue: $67,535.0 Millions
Revenue Year: 2025
Segment: Software
Headquarter: New York, U.S.
Key Geographics: Europe, Middle East, Africa, Asia-Pacific, Americas
Corporate Address: IBM Corporation, New Orchard Road, Armonk, New York 10504, U.S. Tel. +1-914-499-7777 www.ibm.com

Company Overview

International Business Machines (IBM) Corp. is a U.S.-based information technology company that develops integrated solutions leveraging data, information technology, and deep expertise in business processes. It organizes its business operations into four segments: software, consulting, infrastructure, and financing. In validation, calibration, and standardization, it provides digital infrastructure and data management platforms, along with AI-based quality assurance solutions, to ensure compliance with regulations, validate processes, and standardize systems across the biopharmaceutical and biotechnology industries. IBM's partnership with pharmaceutical companies has enabled digital management of the validation lifecycle, predictive maintenance, and remote calibration of equipment through cloud-based systems, as well as hybrid integration approaches.

With a presence in more than 170 countries, IBM continues its work on digital standardization and the modernization of compliance in the global life sciences arena by bringing together advanced analytics, AI, and cloud-based platforms to enhance efficiency, traceability, and regulatory compliance.

Financial Highlights (FY 2025)

Net Revenue: ***
Total Current Liabilities: ***
Total Current Assets: ***
R&D expenses: ***
Operating Income: ***

This information is available for BCC Research members only.

IBM Corp. In Reports

Validation, Calibration, and Standardization in the Life Sciences Market

According to BCC Research detailed report on Validation Calibration and Standardization in the Life Sciences Market revenue ($ Million) for the base year data of 2024 and estimated data for the forecast period 2025...

Cloud Computing in Cell Biology, Genomics and Drug Development: Global Markets

According to BCC Research detailed report on Cloud Computing in Cell Biology, Genomics, and Drug Development Markets revenue ($ Million) for the base year data of 2024 and estimated data for the forecast period 2025...

Global Explainable AI Market

BCC Research detailed report on explainable ai market Using 2024 as the base year, the report provides market estimates for the period 2025 to 2030.

Company's Business Segments

  • Software : Hybrid Platform that includes Red Hat, Automation, Data & AI, Security and Transaction Processing
  • Consulting : Business Transformation, Technology Consulting and Application Operations
  • Infrastructure : Hybrid Infrastructure and Infrastructure Support
  • Financing : Client Financing and Commercial Financing

Applications/End User Industries

  • Banks
  • Insurance
  • Financial Institutions
  • Healthcare Institutions
  • Government Organizations
  • Enterprises
  • Information Technology (IT)
  • Universities
  • Laboratories
  • Research Centers
AI Sentiment